| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $129.9M | — | +38.3% |
| R&D Expense | $15.9M | — | +54.9% |
| SG&A Expense | $37.7M | — | +24.7% |
| Operating Income | $42.7M | — | +68.3% |
| Pre-tax Income | $35.9M | — | +13.8% |
| Income Tax | $9.2M | — | +101.5% |
| Net Income | $26.8M | — | -1.0% |
| EPS (Basic) | $0.15 | — | +7.1% |
| EPS (Diluted) | $0.14 | — | +55.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.8M | -72.6% | -90.7% |
| Accounts Receivable | $70.2M | +3.3% | +31.8% |
| Current Assets | $104.5M | -37.1% | -67.3% |
| Total Assets | $470.9M | -11.3% | -30.7% |
| Current Liabilities | $79.4M | -6.5% | +4.8% |
| Long-term Debt | $391.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $33.5M | — | +40.7% |
| Capital Expenditures | $32K | — | -74.2% |
| Investing Cash Flow | -$1.6M | — | -156.4% |
| Financing Cash Flow | -$95.1M | — | -154.8% |
| Free Cash Flow | $33.4M | — | +41.3% |
| +36.3% |
| Total Liabilities | $470.1M | -2.9% | +30.7% |
| Stockholders' Equity | $839K | -98.2% | -99.7% |